Unknown

Dataset Information

0

Estimation of withdrawal interval recommendations following administration of fenbendazole medicated feed to ring-necked pheasants (Phasianus colchicus).


ABSTRACT:

Introduction

Prescribing fenbendazole medicated feed for pheasants in the USA is considered extra-label drug use under CPG Sec 615.115, and a safe estimated withdrawal interval (WDI) must be applied following administration to this minor food-producing species. This study sought to determine the pharmacokinetic and residue depletion profile for fenbendazole and its major metabolites to estimate a WDI for pheasants following fenbendazole administration as an oral medicated feed.

Method

Pheasants (n = 32) were administered fenbendazole as an oral medicated feed (100 ppm) for 7 days. Fenbendazole, fenbendazole sulfoxide, and fenbendazole sulfone (FBZ-SO2) in liver and muscle samples were analyzed using HPLC-UV. Tissue WDIs were estimated using FDA, European Medicines Agency (EMA), and half-life multiplication methods for US poultry tolerances, EMA maximum residue limits, and the analytical limit of detection (LOD; 0.004 ppm). Terminal tissue elimination half-lives (T1/2) were estimated by non-compartmental analysis using a naïve pooled data approach.

Results

The tissue T1/2 was 14.4 h for liver, 13.2 h for thigh muscle, and 14.1 h for pectoral muscle. The maximum estimated withdrawal interval was 153 h (7 days) for FBZ-SO2 in pectoral muscle using the FDA tolerance method (95% confidence interval for the 99th percentile of the population), and the LOD as the residue limit.

Discussion

The results from this study support the use of FBZ-SO2 as the marker residue in the liver of pheasants and the provision of evidence based WDIs following the extra-label administration of fenbendazole medicated feed (100 ppm) for 7 days.

SUBMITTER: Carreno Gutiez M 

PROVIDER: S-EPMC11322809 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature

altmetric image

Publications

Estimation of withdrawal interval recommendations following administration of fenbendazole medicated feed to ring-necked pheasants (<i>Phasianus colchicus</i>).

Carreño Gútiez Marta M   Mercer Melissa A MA   Martínez-López Beatriz B   Griffith Ronald W RW   Wetzlich Scott S   Tell Lisa A LA  

Frontiers in veterinary science 20240731


<h4>Introduction</h4>Prescribing fenbendazole medicated feed for pheasants in the USA is considered extra-label drug use under CPG Sec 615.115, and a safe estimated withdrawal interval (WDI) must be applied following administration to this minor food-producing species. This study sought to determine the pharmacokinetic and residue depletion profile for fenbendazole and its major metabolites to estimate a WDI for pheasants following fenbendazole administration as an oral medicated feed.<h4>Method  ...[more]

Similar Datasets

| S-EPMC9639844 | biostudies-literature
| S-EPMC8336876 | biostudies-literature
| S-EPMC8743885 | biostudies-literature
| S-EPMC1679874 | biostudies-literature
| S-EPMC10394823 | biostudies-literature
| S-EPMC5640750 | biostudies-literature
| S-EPMC7117390 | biostudies-literature
| S-EPMC6981107 | biostudies-literature
| S-EPMC7297342 | biostudies-literature
| S-EPMC6238775 | biostudies-literature